The Consumer Technology Association (CTA) is collaborating with the American College of Cardiology (ACC) and several vendors on best practices for device and app and wearable device makers to provide deeper understanding of products that manage cardiovascular health. #wearables
May 10, 2021
Vendors and ACC Collaborate With Consumer Technology Association to Help Clinicians and Patients Understand Cardiovascular Devices
May 10, 2021 – Today, the Consumer Technology Association (CTA) announced it is collaborating with the American College…
Read More
The Eko digital stethoscope can record heart soubnds and use an artificial intelligence  (AI) analysis algorithm to detect heart murmurs. I new study in the JAHA showed it has comparable performance to that of an expert cardiologist. Eko Digital Stethoscope AI Analysis Algorithm Validated in JAHA article for Detecting Heart Murmurs
May 10, 2021
Eko Digital Stethoscope AI Analysis Algorithm Validated for Detecting Heart Murmurs
May 10, 2021 — Eko announced the peer-reviewed publication of a clinical study that found that the Eko artificial…
Read More
An example of a patch type cardiac monitor from Vital Connect. These types of inexpensive, stick-on wearable monitors have seen a tremendous increase in use over the past few years, replacing traditional Holter monitors.
May 06, 2021
Wearable Cardiac Devices Market Will See Rapid Expansion in Coming Years
May 6, 2021 — The wearable cardiac devices market is set to grow from its current market was valued at more than $1.2…
Read More
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021
By Dave Fornell, Editor
May 06, 2021
SCAI 2021 Late-breaking Clinical Study Results
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from…
Read More
The Bluegrass Vascular Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. 
May 06, 2021
Case Report on CRT Lead Placement in Obstructed Veins Using Surfacer System
May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility of…
Read More
The Corindus CorPath robotic cath lab navigation system allows operators to sit and control the procedure from behind a lead-lined booth, so they do not have to wear heavy aprons during the procedures.  Christoper Baker, M.D., Hoag Memorial Hospital using the system. #SCAI21 #SCAI2021
May 05, 2021
Second Generation Robotic PCI System Performs Well Across Spectrum of Lesion Complexity
May 5, 2021 — A late-breaking study of the Siemens Healthineers Corindus Corpath GRX second-generation cath lab robotic…
Read More
Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.
May 05, 2021
Avoiding High-risk Cath Lab Procedures Does Not Necessarily Improve Hospital Scores
May 5, 2021 — A late-breaking study presented at the Society for Cardiovascular Angiography and Interventions (SCAI)…
Read More
A nurse checking an ECMO system being used to support a critically ill COVID-19 patient at Banner Health in Phoenix. ECMO can offer both hemodynamic support and oxygenation for COVID patients who otherwise cannot get enough pulmonary support from ventilators, or are in danger of organ failure.
May 04, 2021
Similar Long-Term Outcomes With and Without ECMO for Mechanically Ventilated COVID-19 Patients
May 4, 2021 – A new study, presented today at the 2021 American Association for Thoracic Surgery (AATS) 101st annual…
Read More
If MitraClip Fails 95 Percent of Patients Will Need Full Surgical Valve Replacement according to a late-breaking study at the AATS 2021 meeting. #AATS2021
May 04, 2021
If MitraClip Fails 95 Percent of Patients Will Need Surgical Valve Replacement
May 4, 2021 – A new study, presented at the 2021 American Association for Thoracic Surgery (AATS) 101st annual meeting…
Read More
8 Essential Steps for a Successful cardiovascular information system (CVIS) or PACS Implementation. Getty Images
By Jef Williams
May 04, 2021
8 Essential Steps for a Successful CVIS or PACS Implementation
You have selected a vendor for your new cardiovascular information system (CVIS) or PACS. Congratulations. Most likely…
Read More
One third of patients will die who have COVID-19 (SARS-CoV-2) and suffer a ST-elevated myocardial infarction (STEMI), according to the latest, comprehensive data from The North American COVID-19 Myocardial Infarction (NACMI) Registry. The data was presented as a late-breaking study at the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 Scientific Sessions. The study showed there was an alarming one-in-three patients dying with STEMI and COVID, compared to 4-in-100 #SCAI2021
By Dave Fornell, Editor
May 03, 2021
Third of COVID Patients With STEMI Heart Attacks Die
May 3, 2021 – One third of patients will die who have COVID-19 (SARS-CoV-2) and suffer a ST-elevated myocardial…
Read More
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images
May 03, 2021
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for…
Read More
The NuMED 10-zig Covered CP (CCP) balloon expandable covered stent. It is used for repair of sinus venosus atrial septal defects (SVASD). #SVASD #SCAI2021 #congenitalheart #
May 01, 2021
Global registry Shows Longer Stent Minimizes Procedure Complications in Sinus Venosus Atrial Septal Defects
May 1, 2021 - An analysis of a new international registry reveals benefits of using a longer covered stent for…
Read More
The Medtronic Harmony transcatheter pulmonary valve (TPV) system offers a less invasive treatment option for patients with a congenital heart defect irregularity in their right ventricular outflow tract (RVOT) that requires a pulmonary valve placement to restore valve function. 
Dave Fornell, Editor
April 30, 2021
One-year Results of the Harmony Transcatheter Pulmonary Valve Trial Presented at SCAI 2021 
April 30, 2021 — New study results validate the effectiveness of the Medtronic Harmony transcatheter pulmonary valve (…
Read More
The two FDA-clear transcatheter aortic valve replacement (TAVR) valves on the market, the Edwards Lifesciences Sapien 3 (left) and the Medtronic CoreValve (right).
April 30, 2021
TAVR Access is Inequitable Based Socioeconomics Level and Geography
April 30, 2021 – An analysis of growth patterns in transcatheter aortic valve replacement (TAVR) programs across United…
Read More
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
April 29, 2021
Young African Americans With Coronary Disease Impacted by Non-traditional Risk Factors
April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American…
Read More
The Abiomed Impella percutaneous heart pump was shown in the NCSI study to greatly improve survival of acute myocardial infarction with cardiogenic shock (AMICS), raising survival from 50 percent to 71 percent. Ambulance image from Getty Images.
By Dave Fornell, Editor
April 29, 2021
National Cardiogenic Shock Initiative Protocol Shows 71 Percent Survival 
April 29, 2021 — The results of a large, national heart attack study show that patients with  cardiogenic shock…
Read More
A Chinese registry study found there are higher event rates in patients with shorter dual-antiplatelet therapy (DAPT) after PCI procedures. There has been a lot of movement toward using shorter duration DAPT with newer generation drug-eluting stent technologies, but this study reinforces the need longer DAPT in many patients. The findings were presented as a late-breaking trial at SCAI 2021 today. 
April 28, 2021
Long-term Dual Antiplatelet Therapy Benefits Reinforced in SCAI Late-breaking Study
April 28, 2021 — An analysis of the prospective Chinese Fuwai PCI Registry, confirms long-term, dual-antiplatelet…
Read More
The STAT2 trial used a combination of the Biolife Statseal potassium ferrate hemostatic patch and a Terumo TR Band to reduce radial access arteriotomy site hemostasis by 50 percent.
Dave Fornell, Editor
April 28, 2021
Radial Hemostasis Time Cut by 50 Percent With StatSeal in Combination With TR Band
April 28, 2021 — A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to…
Read More
There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 
April 28, 2021
COVID Caused Major Decline in Heart Attack Patients Seeking Care
April 28, 2021 – Results from a retrospective observational study, presented today at Society for Cardiovascular…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now